ACCPL
Invest Now
Start SIP in
ACCPL
Performance
- Low
- ₹77
- High
- ₹80
- 52 Week Low
- ₹63
- 52 Week High
- ₹83
- Open Price₹80
- Previous Close₹78
- Volume28,800
Investment Returns
- Over 1 Month -23.76%
- Over 3 Month -23.76%
- Over 6 Month -23.76%
- Over 1 Year -23.76%
Smart Investing Starts Here Start SIP with Accretion Pharmaceuticals for Steady Growth!
Accretion Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 12.6
- PEG Ratio
- -
- Market Cap Cr
- 86
- P/B Ratio
- 5.2
- Average True Range
- 3.97
- EPS
- 6.11
- Dividend Yield
- 0
- MACD Signal
- -
- RSI
- 43.79
- MFI
- 52.92
Accretion Pharmaceuticals Financials
Accretion Pharmaceuticals Technicals
EMA & SMA
Current Price
₹77.00
-1.3
(-1.66%)

-
- Bearish Moving Average 1
-
- Bullish Moving Average 6
- 20 Day
- ₹71.70
- 50 Day
- -
- 100 Day
- -
- 200 Day
- -
Resistance and Support
77.92
- R3 81.58
- R2 80.67
- R1 78.83
- S1 76.08
- S2 75.17
- S3 73.33
Accretion Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-06-10 | Audited Results & Others | To consider Other business matters. |
Accretion Pharmaceuticals F&O
About Accretion Pharmaceuticals
- NSE Symbol
- ACCPL
- BSE Symbol
- ISIN
- INE0T8T01010
Similar Stocks to Accretion Pharmaceuticals
Accretion Pharmaceuticals FAQs
Accretion Pharmaceuticals share price is ₹77 As on 18 June, 2025 | 07:28
The Market Cap of Accretion Pharmaceuticals is ₹85.6 Cr As on 18 June, 2025 | 07:28
The P/E ratio of Accretion Pharmaceuticals is 12.6 As on 18 June, 2025 | 07:28
The PB ratio of Accretion Pharmaceuticals is 5.2 As on 18 June, 2025 | 07:28
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.